Fatty Acid Diffusion Kinetics for Pet Stress Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for reducing stress and anxiety in non-human mammals, such as cats and dogs, often require repeated application of fatty acid emulsions or sprays and can be inefficient due to slow diffusion kinetics, which may not effectively address sudden environmental changes causing stress.
Innovation Solution
A mixture of pure fatty acids and their derivatives, administered through rapid air diffusion for short periods, achieving higher diffusion kinetics than traditional methods, with compositions comprising 77-94% fatty acids or their ester/methyl ester derivatives, which maintain stability at high temperatures and are specifically formulated for cats, dogs, and pigs to reduce stress and anxiety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional fatty acid emulsions or sprays are used, then stress and anxiety symptoms can be reduced, but repeated application is required and diffusion kinetics are slow
Solution Approach 1:
The invention changes the physical-chemical parameters of the fatty acid composition by using pure fatty acids instead of emulsions, and by controlling the diffusion kinetics parameters (initial rapid diffusion followed by sustained release), thereby achieving effective stress reduction with single application
Solution Approach 2:
The diffusion process follows a periodic pattern with an initial rapid diffusion phase followed by a sustained release phase, optimizing the temporal distribution of fatty acids to maintain effectiveness without repeated application
2Reliability
If fatty acid emulsions are used, then stress reduction can be achieved, but diffusion kinetics are slow and require long periods
Solution Approach 1:
The invention fundamentally changes the diffusion kinetics parameters by using pure fatty acids that diffuse rapidly initially and then sustain release, compared to the slow continuous diffusion of emulsions, achieving effective stress reduction in shorter time periods
3Stability of the object's composition
If electric diffusion devices are used with conventional kinetics, then fatty acids diffuse slowly over long periods, but the kinetics are constant over time rather than rapid initially
Solution Approach 1:
The invention implements a time-dependent diffusion pattern where the diffusion rate is high initially and then decreases to a sustained lower rate, optimizing both the speed of action and the stability of release over time, unlike constant kinetics devices
4Speed
If pure fatty acids are used with rapid diffusion kinetics, then stress reduction is achieved quickly, but the fatty acids must remain stable at high temperatures
Solution Approach 1:
The invention selects specific pure fatty acids and their derivatives that possess both the desired rapid diffusion kinetics and adequate thermal stability at diffusion temperatures around 120°C, optimizing the balance between speed of action and compositional stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively reduces stress and anxiety-related behaviors in non-human mammals by providing a rapid and sustained appeasing effect, significantly improving their behavior and reducing territorial marking, noise, and destructive behaviors, with a notable reduction in urinary marking in cats.
Implementation Method 1
administered to non-human mammals by diffusion in the ambient air with rapid kinetics of diffusion during the first three days
Implementation Method 2
heated to approximately 120° C. to allow their diffusion in the air
Data Source
AI summary
Mixture of fatty acids, their derivatives, ester or methyl ester derivates thereof, which may be administered to non-human mammals by diffusion in to ambient air during at least seven consecutive days, with a rapid kinetic of diffusion during the first three days of administration.